Synergistic Efficacy of Calcitriol Combined with Denosumab versus Calcitriol Alone in Postmenopausal Osteoporosis: A Retrospective Cohort Study
Xueyuan Li, Ming Hu, Yi Shen · 2026
Read Synergistic Efficacy of Calcitriol Combined with Denosumab versus Calcitriol Alone in Postmenopausal Osteoporosis: A Retrospective Cohort Study by Xueyuan Li, Ming Hu, Yi Shen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13213173.txt.
Description
Xueyuan Li, Ming Hu, and Yi Shen compare in 2026 two drug regimens for bone loss in women after menopause. One group received an active vitamin D compound alone with calcium, while the other added denosumab, an injected antibody that slows bone breakdown.
Records for 306 women treated over twelve months showed the combined group gained more bone density at spine, hip neck, and total hip. Bone turnover markers fell further, calcium balance measures improved, and pain, disability, and daily function scores all improved more. Side effects stayed low and similar in both groups, with none judged serious. The pairing looks promising, though the retrospective design invites a confirming trial.
Catalog record
| CREATOR | Xueyuan Li, Ming Hu, Yi Shen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |